AbCellera Biologics Inc. (NASDAQ:ABCL) Q2 2025 Earnings Call Transcript

AbCellera Biologics Inc. (NASDAQ:ABCL) Q2 2025 Earnings Call Transcript August 7, 2025

AbCellera Biologics Inc. beats earnings expectations. Reported EPS is $-0.12, expectations were $-0.17.

Operator: Good afternoon, and welcome to AbCellera’s Second Quarter 2025 Business Update Conference Call. My name is Jason, and I’ll facilitate the audio portion of today’s interactive broadcast. At this time, I would like to turn the call over to Tryn Stimart, AbCellera’s Chief Legal and Compliance...